This study is currently not recruiting participants.

Natural History After Avastin Treatment

Investigation of Investigational Treatment Effects on ROP

Not Recruiting
100 years or below
All
Phase N/A

Brief description of study.

This study is looking at the natural history of Avastin treatment on ROP patients.

Detailed description of study

This study is looking at the natural history of Avastin treatment on ROP patients.

Eligibility of study

You may be eligible for this study if you meet the following criteria:

  • Conditions: retinopathy of prematurity
  • Age: 100 years or below
  • Gender: All

This study investigates the effects of an investigational medication on patients with Retinopathy of Prematurity (ROP). ROP is a condition that affects the eyes of premature infants, potentially leading to vision problems.

Participants in this study will receive either the investigational medication or a placebo. A placebo is an inactive substance that looks like the investigational medicine but does not contain any medicine.

  • Who can participate: The study is open to premature infants diagnosed with Retinopathy of Prematurity (ROP).
  • Study details: Participants will receive either the investigational medication or a placebo.
Updated on 19 Feb 2024. Study ID: 1707408875

Interested in the study?

Select a study center that’s convenient for you, and get in touch with the study team.

Connect with the study team